JPRN-UMIN000007871已完成2 期
An exploratory study of chemotherapy enhancement effects of mefenamic acid and cilostazol in patients with locally advanced head & neck cancer - Exploratory study of chemotherapy enhancement effects of mefenamic acid and cilostazol
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Gastric ulcer 2) Severe hematological, hepatic, renal or cardiac disorder 3) History of severe hypersensitivity to the ingredients of an agent used in this study 4) Aspirin asthma or its history 5) Uncontrolled hypertension 6) History of diarrhea in the use of mefenamic acid or cilostazol 7) Receiving anticoagulant therapy 8) Bleeding or bleeding tendency 9) Congestive heart failure 10) Pregnant 11) Lactating women 12) Psychotic disorder 13) Receiving systemic steroid therapy 14) Patients with any other conditions whom the doctor determined to be inappropriate for this study
研究者
相似试验
已完成
不适用
Evaluation of effect of chemotherapy for depiction of metastatic liver tumor on gadoxetate disodium enhanced MRIJPRN-UMIN000005401Hiroshima University20
进行中（未招募）
1 期
Study evaluating the effects of chemotherapy on incurable cancer of the esophagus or stomachEsophagogastric adenocarcinomaMedDRA version: 18.1Level: PTClassification code 10062878Term: Gastrooesophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-000127-24-DKRigshospitalet, Department of Oncology98
尚未招募
3 期
Effect and Mechanism of TCM-TSKSR on Advanced Colon Cancer: A Randomized Placebo-Controlled Clinical TrialITMCTR1900002315Xiyuan Hospital, China Academy of Chinese Medical Sciences
已完成
1 期
Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder CancerBladder CancerNCT00318643Halozyme Therapeutics27
Unknown
不适用
Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction CarcinomaEsophagogastric Junction CancerNCT03211377Anyang Tumor Hospital120